Literature DB >> 22654362

Bone regeneration in osseous defects using hydroxyapatite graft and the extent of ossification in osseous defects treated without grafts: a comparative evaluation.

Ravi Shankar1, Deepak Singh, Shoyeb Shaikh, Gaurav Singh, Anurag Yadav, Ravi Jain.   

Abstract

OBJECTIVES: Objective of this study is to evaluate the new bone formation in bony defects following insertion of hydroxyapatite graft and to compare the efficacy and regenerative potential of this bone graft material.
METHOD: The patients having osseous defects after surgery were selected. Preoperatively a brief history, examination, relevant blood investigation and radiographs were taken. Post operative observation period of 6 months was planned. Radiographic and bone scintigraphic (isotope study of bone activity) evaluation of bone specimens was completed in defined time.
RESULTS: Radiographic evaluation indicated increased calcification surrounding the material, indicative of acceptance of the graft to the bone. Bone scintigraphic evaluation indicated area of increased bone metabolism and is evidenced as area of increased radiotracer uptake, namely 'hot spots' (active bone formation).
CONCLUSION: It can be concluded that the hydroxyapatite graft met the clinical requirement of a bone substitute material which is biocompatible and non-allergic. The use of this material is advantageous over other bone grafts because of simplicity of application, cost effectiveness and easy availability. Due to its microstructure, complete resorption and neo bone formation took place during the course of this study.

Entities:  

Keywords:  Bone regeneration; Hydroxyapatite; Osseous defects

Year:  2011        PMID: 22654362      PMCID: PMC3177528          DOI: 10.1007/s12663-011-0189-x

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  11 in total

Review 1.  Bone growth factors.

Authors:  S Mohan; D J Baylink
Journal:  Clin Orthop Relat Res       Date:  1991-02       Impact factor: 4.176

2.  Platelet-rich plasma: Growth factor enhancement for bone grafts.

Authors:  R E Marx; E R Carlson; R M Eichstaedt; S R Schimmele; J E Strauss; K R Georgeff
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-06

Review 3.  The role of growth factors in wound healing.

Authors:  D G Greenhalgh
Journal:  J Trauma       Date:  1996-07

4.  Porous hydroxyapatite as an onlay bone-graft substitute for maxillofacial surgery.

Authors:  K E Salyer; C D Hall
Journal:  Plast Reconstr Surg       Date:  1989-08       Impact factor: 4.730

Review 5.  The biology of platelet-derived growth factor.

Authors:  R Ross; E W Raines; D F Bowen-Pope
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

6.  Bone development and repair.

Authors:  A I Caplan
Journal:  Bioessays       Date:  1987-04       Impact factor: 4.345

7.  A histologic evaluation of a mandibular cross section one year after augmentation with hydroxyapatite particles.

Authors:  K Donath; M D Rohrer; J Beck-Mannagetta
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1987-06

8.  Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells.

Authors:  J E Wergedal; S Mohan; M Lundy; D J Baylink
Journal:  J Bone Miner Res       Date:  1990-02       Impact factor: 6.741

9.  The use of hydroxyapatite and autogenous cancellous bone grafts to repair bone defects in rats.

Authors:  R V Silva; J A Camilli; C A Bertran; N H Moreira
Journal:  Int J Oral Maxillofac Surg       Date:  2005-03       Impact factor: 2.789

10.  The combined use of hydroxylapatite segments and granules for alveolar ridge reconstruction.

Authors:  A B Schaffer
Journal:  J Oral Maxillofac Surg       Date:  1993-01       Impact factor: 1.895

View more
  1 in total

1.  Development and biological evaluation of fluorophosphonate-modified hydroxyapatite for orthopaedic applications.

Authors:  Gráinne Neary; Ashley W Blom; Anna I Shiel; Gabrielle Wheway; Jason P Mansell
Journal:  J Mater Sci Mater Med       Date:  2018-07-21       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.